Trial Profile
Post-cesarean Section Analgesic Safety and Efficacy of EXPAREL (Liposomal Bupivacaine) Infiltration Locally Versus Transversus Abdominis Plane Infiltration
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2021
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 14 May 2021 Planned End Date changed from 1 Sep 2020 to 1 Sep 2019.
- 14 May 2021 Planned primary completion date changed from 30 Jun 2020 to 30 Aug 2019.
- 14 May 2021 Status changed from recruiting to discontinued with reason the study was stopped as lack of resources, no data collected.